Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long-term potentiation (LTP) is a persistent strengthening of synapses based on recent patterns of activity, widely regarded as a key cellular mechanism underlying learning and memory [StatPearls]. It is characterized by a long-lasting increase in the efficiency of synaptic transmission following high-frequency stimulation of a presynaptic neuron, primarily occurring in the hippocampus and other cortical regions [Wikipedia]. At the molecular level, LTP induction typically requires the activation of N-methyl-D-aspartate (NMDA) receptors, which leads to calcium influx and the subsequent activation of intracellular kinases like CaMKII that promote the insertion of AMPA receptors into the postsynaptic membrane [Nature Reviews Neuroscience]. Dysregulation of LTP is implicated in various neurological and psychiatric conditions, including Alzheimer’s disease, where synaptic loss and impaired plasticity drive cognitive decline [PubMed: 15217329]. While LTP is a physiological process rather than a single molecular target, therapeutic strategies often focus on modulating the glutamatergic system or neurotrophic factors to restore or enhance LTP in diseased states [NCBI]. However, pharmacological modulation of these pathways must be carefully managed, as excessive synaptic potentiation can lead to neurotoxicity or the development of epilepsy [StatPearls].
Enhancement of synaptic efficacy via the activation of N-methyl-D-aspartate (NMDA) receptors, calcium-dependent signaling cascades (e.g., CaMKII), and the trafficking of AMPA receptors to the postsynaptic membrane [StatPearls, PubMed: 15217329].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long-term potentiation (LTP).